Website review helsinnhealthcare.swiss
Generated on December 06 2025 23:11 PM
Old data? UPDATE !
The score is 46/100
SEO Content
Title
Helsinn
Length : 7
Ideally, your title should contain between 10 and 70 characters (spaces included). Use this free tool to calculate text length.
Description
Length : 0
Very bad. We haven't found meta description on your page. Use this free online meta tags generator to create description.
Keywords
Very bad. We haven't found meta keywords on your page. Use this free online meta tags generator to create keywords.
Og Meta Properties
Good, your page take advantage of Og Properties.
| Property | Content |
|---|---|
| type | website |
| locale | en-001 |
| site_name | Helsinn |
| description | Helsinn is a fully integrated biopharma company with a track record of over forty years of commercial execution and a strong focus in oncology and rare diseases. |
| image:width | 1200 |
| image:height | 627 |
Headings
| H1 | H2 | H3 | H4 | H5 | H6 |
| 0 | 19 | 5 | 0 | 0 | 0 |
- [H2] About Us
- [H2] Products
- [H2] Business
- [H2] Technology
- [H2] ESG
- [H2] Patients
- [H2] Helsinn
- [H2] About us
- [H2] Technology
- [H2] A comprehensive technical organization
- [H2] Business
- [H2] The partner of choice
- [H2] ESG
- [H2] Committed to responsible business growth
- [H2] News
- [H2] Read our news and insights
- [H2] Exiting the US site
- [H2] Entering the US site
- [H2] You are now leaving helsinn.com
- [H3] AKYNZEO® demonstrates superior prevention of chemotherapy-induced nausea and vomiting compared to the standard of care in patients receiving Moderately Emetogenic Chemotherapy with additional predictive factorsResults from the MyRisk clinical trial, accepted for publication in the Annals of Oncology, will be presented today at ESMO 2025 as an oral presentation
- [H3] AKYNZEO® demonstrates superior prevention of chemotherapy-induced nausea and vomiting compared to the standard of care in patients receiving Moderately Emetogenic Chemotherapy with additional predictive factorsResults from the MyRisk clinical trial, accepted for publication in the Annals of Oncology, will be presented today at ESMO 2025 as an oral presentation
- [H3] Helsinn Group submits a new formulation of AKYNZEO® to the European Medicines Agency (EMA)
- [H3] AnaCardio receives patent grant in Europe for AC01
- [H3] Knight Therapeutics and Helsinn Healthcare SA expand relationship and enter into exclusive license, distribution, and supply agreement for Onicit®
Images
We found 9 images on this web page.
5 alt attributes are empty or missing. Add alternative text so that search engines can better understand the content of your images.
Text/HTML Ratio
Ratio : 9%
This page's ratio of text to HTML code is below 15 percent, this means that your website probably needs more text content.
Flash
Perfect, no Flash content has been detected on this page.
Iframe
Too Bad, you have Iframes on the web pages, this mean that content in an Iframe cannot be indexed.
SEO Links
URL Rewrite
Good. Your links looks friendly!
Underscores in the URLs
Perfect! No underscores detected in your URLs.
In-page links
We found a total of 41 links including 0 link(s) to files
| Anchor | Type | Juice |
|---|---|---|
| Skip to content | Internal | Passing Juice |
| Choose region | Internal | Passing Juice |
| Mission, Vision and Values | External | Passing Juice |
| Leadership | External | Passing Juice |
| Our Story | External | Passing Juice |
| Our Global Reach | External | Passing Juice |
| Akynzeo® | External | Passing Juice |
| Aloxi® Onicit® Paloxi® | External | Passing Juice |
| Arokaris® | External | Passing Juice |
| Adlumiz® | External | Passing Juice |
| Valchlor®/Ledaga® | External | Passing Juice |
| Aulin® Mesulid® Nisulid® | External | Passing Juice |
| Our Business Model | External | Passing Juice |
| Business Development | External | Passing Juice |
| In-Licensing | External | Passing Juice |
| Partnering | External | Passing Juice |
| Our Partnerships | External | Passing Juice |
| Manufacturing and Supply | External | Passing Juice |
| Life-Cycle Development | External | Passing Juice |
| Research Grants | External | Passing Juice |
| Sustainability | External | Passing Juice |
| Carbon Neutral Company | External | Passing Juice |
| Ethics and Governance | External | Passing Juice |
| Codes of Conduct and Ethics | External | Passing Juice |
| Reporting Channels | External | Passing Juice |
| Compliance | External | Passing Juice |
| Clinical Data Sharing Governance | External | Passing Juice |
| Commitment to Patients | External | Passing Juice |
| Early Access Programs | External | Passing Juice |
| Educational Grants | External | Passing Juice |
| About Us | External | Passing Juice |
| Products | External | Passing Juice |
| Business | External | Passing Juice |
| Technology | External | Passing Juice |
| ESG | External | Passing Juice |
| Patients | External | Passing Juice |
| Life-cycle development | External | Passing Juice |
| Helsinn Group submits a new formulation of AKYNZEO® to the European Medicines Agency (EMA) | External | Passing Juice |
| Partnership | External | Passing Juice |
| AnaCardio receives patent grant in Europe for AC01 | External | Passing Juice |
| Knight Therapeutics and Helsinn Healthcare SA expand relationship and enter into exclusive license, distribution, and supply agreement for Onicit® | External | Passing Juice |
SEO Keywords
Keywords Cloud
global products learn helsinn patients governance ethics more development business
Keywords Consistency
| Keyword | Content | Title | Keywords | Description | Headings |
|---|---|---|---|---|---|
| patients | 20 |  |
|
|
 |
| business | 17 | |
|
|
|
| more | 13 | |
|
|
|
| helsinn | 11 | |
|
|
|
| development | 10 | |
|
|
|
Usability
Url
Domain : helsinnhealthcare.swiss
Length : 23
Favicon
Great, your website has a favicon.
Printability
We could not find a Print-Friendly CSS.
Language
Good. Your declared language is en.
Dublin Core
This page does not take advantage of Dublin Core.
Document
Doctype
HTML 5
Encoding
Perfect. Your declared charset is UTF-8.
W3C Validity
Errors : 0
Warnings : 0
Email Privacy
Great no email address has been found in plain text!
Deprecated HTML
Great! We haven't found deprecated HTML tags in your HTML.
Speed Tips
|
Excellent, your website doesn't use nested tables. |
|
Too bad, your website is using inline styles. |
|
Too bad, your website has too many CSS files (more than 4). |
|
Too bad, your website has too many JS files (more than 6). |
|
Perfect, your website takes advantage of gzip. |
Mobile
Mobile Optimization
|
Apple Icon |
|
Meta Viewport Tag |
|
Flash content |
Optimization
XML Sitemap
Great, your website has an XML sitemap.
| https://helsinn.com/ |
Robots.txt
http://helsinnhealthcare.swiss/robots.txt
Great, your website has a robots.txt file.
Analytics
Missing
We didn't detect an analytics tool installed on this website.
Web analytics let you measure visitor activity on your website. You should have at least one analytics tool installed, but It can also be good to install a second in order to cross-check the data.
PageSpeed Insights
Device
Categories
Website-SEO-Überprüfung
Website-SEO-Überprüfung is a free SEO tool which provides you content analysis of the website.